Remove DEA Remove Legalization Remove Marijuana Remove Policy
article thumbnail

DEA: Marijuana Plant Seizures Spike, Arrests Fall in 2019

NORML

Federal law enforcement agents and their partners made fewer marijuana-related arrests in 2019, but seized a far greater number of plants than they did the year before, according to annual data compiled by US Drug Enforcement Administration. It was the second-lowest number of arrests reported by the DEA in the past decade.

DEA 279
article thumbnail

Court: DEA Must Explain Its Failure to Act Upon Pending Marijuana Cultivation Applications

NORML

A federal court has ordered the Drug Enforcement Administration to respond to a lawsuit charging the agency with failing to move forward with a 2016 policy to expand the total number of federally licensed marijuana cultivators. “[This filing is] asking the court for an order compelling the DEA to process our application.

DEA 220
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biden Administration Eyes Major Shift In Marijuana Policy, Reports Say

Medical Marijuana Program Connection

Reuters Reports have surfaced indicating that the Biden administration is gearing up to shake up federal drug policy. Drug Enforcement Administration (DEA) is reportedly considering reclassifying marijuana, a move that could mark a significant shift in decades-long restrictions. Read More

Policy 49
article thumbnail

NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules

NORML

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

article thumbnail

Federal Marijuana Reclassification Is on the Horizon

CannaMD

The recommendation by the FDA and HHS to reclassify marijuana as a Schedule III substance marks a pivotal shift in federal drug policy, acknowledging its medical benefits and potential for lower abuse.

DEA 96
article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 160
article thumbnail

Tell Congress Not To Allow Trump To Roll Back Medical Marijuana Protections

NORML

It’s been three years and counting but President Trump is once again threatening to derail the progress we’ve made in reforming marijuana laws across this country. Sign our petition to demand Congress protect state-legal medical marijuana programs. The data speaks for itself.

Marijuana 352